Antibiotice Iaşi posted a 25% increase in profit after the first quarter of 2020
The Romanian drug manufacturer Antibiotice Iaşi posted a net profit increasing by 25% after the first three months of this year, to 4.08 million lei, due to the tax exemption facility for the profit invested in technological equipment, it is shown in a communiqué of the company sent on Tuesday to the Bucharest Stock Exchange. The operating profit increased, on March 31, by 6%, to 5.45 million lei, from 5.17 million lei, in the similar period of last year.
Comments
Comments are closed.